Literature DB >> 3489764

Limiting dilution analysis of the stem cells for T cell lineage.

Y Katsura, T Kina, T Amagai, T Tsubata, K Hirayoshi, Y Takaoki, T Sado, S I Nishikawa.   

Abstract

Stem cell activities of bone marrow, spleen, thymus, and fetal liver cells for T cell lineage were studied comparatively by transferring the cells from these organs through i.v. or intrathymus (i.t.) route into right leg- and tail-shielded (L-T-shielded) and 900 R-irradiated recipient mice, which were able to survive without supplying hemopoietic stem cells. Cells from B10.Thy-1.1 (H-2b, Thy-1.1) mice were serially diluted and were transferred into L-T-shielded and irradiated C57BL/6 (H-2b, Thy-1.2) mice, and 21 days later the thymus cells of recipient mice were assayed for Thy-1.1+ cells by flow cytofluorometry. The percentage of recipient mice possessing donor-type T cells was plotted against the number of cells transferred, and the stem cell activity in each cell source was expressed as the 50% positive value, the number of donor cells required for generating donor-type T cells in the thymuses of 50% of recipient mice. In i.v. transfer experiments, the activity of bone marrow cells was similar to that of fetal liver cells, and about 100 times and nearly 1000 times higher than those of spleen cells and thymus cells, respectively. In i.t. transfer experiments, the number of cells required for generating donor-type T cells was much lower than that in i.v. transfer experiments, although the ratio in 50% positive values between i.v. and i.t. transfers differed among cell sources. In i.t. transfers, the 50% positive value of bone marrow cells was five times, 400 times, and 500 times higher than that of fetal liver cells, spleen cells, and thymus cells, respectively. Our previous finding that stem cells are enriched in the spleens of mice which were whole body-irradiated and marrow-reconstituted 7 days earlier was confirmed also by the present limiting dilution assay carried out in i.v. as well as i.t. transfers.

Entities:  

Mesh:

Year:  1986        PMID: 3489764

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Antibody which defines a subset of bone marrow cells that can migrate to thymus.

Authors:  H C O'Neill
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

2.  Enhancement of activation-induced cell death by fibronectin in murine CD4+ CD8+ thymocytes.

Authors:  E Takayama; T Kina; Y Katsura; T Tadakuma
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

Review 3.  Phenotypic and genotypic characteristics of the human prothymocyte.

Authors:  J J van Dongen; W M Comans-Bitter
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  Differentiation of CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8- intermediate.

Authors:  D L Kraft; I L Weissman; E K Waller
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

5.  Two rare populations of mouse Thy-1lo bone marrow cells repopulate the thymus.

Authors:  G J Spangrude; C E Muller-Sieburg; S Heimfeld; I L Weissman
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.